Skip to content

Visuomotor Control in Parkinson Disease

Unraveling Visuomotor Control in Parkinson Disease With and Without Freezing of Gait

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06918938
Enrollment
63
Registered
2025-04-09
Start date
2025-07-19
Completion date
2027-12-31
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson disease, Transcranial magnetic stimulation, Motor control

Brief summary

Visuomotor processing is the ability to integrate visual information into motor plans and movement correction, which is highly required in daily activities such as writing and walking. As visual impairments have been reported in people with Parkinson's disease (PD), it is likely that those impairments may affect visuomotor processing ability and subsequently impair motor performance. Furthermore, people with PD and freezing of gait (FOG) have exhibited poorer visual perception than those without FOG, yet the differences of visuomotor control have not been well investigated. Additionally, little did the studies apply neurophysiological assessment to investigate the associated neural mechanisms. This study aims to investigate behavioral and neurophysiological differences in visuomotor control among people with PD and FOG (freezers), without FOG (non-freezers), and age-matched healthy controls. Sixty-three participants, 21 freezers, 21 non-freezers, and 21 age-matched healthy controls, will be enrolled in this study. Behavioral assessments, including a manual control task and visual perception tests will be used to evaluate visuomotor and visual perceptual abilities. Neurophysiological correlates, including corticomotor excitability and corticocortical connectivity between V1-M1 and PPC-M1, will be examined using transcranial magnetic stimulation. It is hypothesized that freezers will demonstrate the greatest visuomotor impairments and disrupted corticocortical connectivity compared to non-freezers and controls. By integrating behavioral and neurophysiological outcomes, this study seeks to unravel the mechanisms linking visual and motor impairments to FOG, ultimately providing insights into targeted interventions to improve visuomotor processing and motor performance in PD.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age above 18 * able to follow the researchers' instructions * normal or correct-to-normal vision to view a computer screen

Exclusion criteria

* neurological disorders other than PD * diagnosed psychological disorders or a tendency of anxiety and/or depression * a self-history of seizure or a family history of epilepsy * deep brain stimulation or pacemaker implanted * unstable cardiovascular diseases or other uncontrolled medical conditions * pregnant * surgical history, severe injury, or severe tremor of their upper extremities that can affect their movements in the past 6 months

Design outcomes

Primary

MeasureTime frameDescription
Root-mean square-errorDay 1Overall performance accuracy relative to the target waveform, which is the mean difference between the target waveform and the participant's movement trajectory calculated over their actual movement time.
Directional errorDay 1The value of the instantaneous component of the hand movement vector, perpendicular to the target trajectory in every sampled time point, which will be calculated and expressed as a percentage of the total movement vector
Squared mean jerkDay 1The squared mean of the jerk of the visuomotor trajectory, which a minor JSM is assumed a major smoothness by better controlling the movement.
Movement timeDay 1Total movement time of a trial will be recorded.
Tracking interruptionDay 1Frequency and duration of tracking interruptions will be recorded when the participant's cursor exits the target circle.

Secondary

MeasureTime frameDescription
Benton Judgment of Line Orientation TestDay 2A 30-item neuropsychological assessment of visuospatial ability. Participants are required to match 2 angled line portions on the top page to an array of 11 target lines, and the correction rate will be recorded.
Random dot cinematogramDay 2A psychological assessment of visual motor perception. Participants need to distinguish the coherent motion direction, and the correction rate and minimal detectable threshold of coherence will be recorded.
National Eye Institute Visual Function Questionnaire-25Day 2A 25-item self-reported questionnaire of visual-related activities, which the total score will be recorded.
Purdue Pegboard TestDay 2A behavioral assessment of hand dexterity ability. Participants are instructed to use one or both hands to sequentially move as many pegs into two parallel rows of holes as possible, within a set time limit, and the movement time will be recorded.
Timed Up and Go TestDay 2A behavioral assessment of dynamic balance ability. Participants will be instructed to rise from a chair, walk for 3 meters, turn around, return to the chair, and sit down, and the movement time will be recorded.
Movement Disorder Society Unified Parkinson's Disease Rating ScaleDay 1A comprehensive scale of Parkinson disease characteristics, including non-motor aspects of experiences of daily living, motor aspects of experiences of daily living, motor examination, and motor complications. Scores of each subscales will be recorded.
New Freezing of Gait QuestionnaireDay 1A self-reported questionnaire to evaluate the frequency and severity of freezing of gait in people with PD, which the total score will be recorded.
Cortical excitabilityDay 1 and Day 2Transcranial magnetic stimulation (TMS) device (The Magstim Company Ltd, Whitland, UK) will be used to determine the neurophysiology of corticomotor excitability.
Corticocortical connectivityDay 1 and Day 2Transcranial magnetic stimulation (TMS) device (The Magstim Company Ltd, Whitland, UK) will be used to determine the neurophysiology of corticocortical connectivity.

Countries

Taiwan

Contacts

CONTACTYa-Yun Lee, PhD
yayunlee@ntu.edu.tw+886-2-33668155
CONTACTSung-Hao Lu
d12428001@ntu.edu.tw+886-9-79880052
PRINCIPAL_INVESTIGATORGraduate Institute of Physical Therapy

National Taiwan University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026